Your browser doesn't support javascript.
loading
High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization.
Maria G Noval; Maria E Kaczmarek; Akiko Koide; Bruno A Rodriguez-Rodriguez; Ping Louie; Takuya Tada; Takamitsu Hattori; Tatyana Panchenko; Larizbeth A Romero; Kai Wen Teng; Andrew Bazley; Maren de Vries; Marie I Samanovic; Jeffrey N Weiser; Ioannis Aifantis; Joan Cangiarella; Mark J Mulligan; Ludovic Desvignes; Meike Dittmann; Nathaniel R Landau; Maria E Aguero-Rosenfeld; Shohei Koide; Kenneth A Stapleford Jr..
Afiliação
  • Maria G Noval; New York University School of Medicine
  • Maria E Kaczmarek; New York University School of Medicine
  • Akiko Koide; New York University School of Medicine
  • Bruno A Rodriguez-Rodriguez; New York University School of Medicine
  • Ping Louie; New York University School of Medicine
  • Takuya Tada; New York University School of Medicine
  • Takamitsu Hattori; New York University School of Medicine
  • Tatyana Panchenko; New York University School of Medicine
  • Larizbeth A Romero; New York University School of Medicine
  • Kai Wen Teng; New York University School of Medicine
  • Andrew Bazley; New York University School of Medicine
  • Maren de Vries; New York University School of Medicine
  • Marie I Samanovic; New York University School of Medicine
  • Jeffrey N Weiser; NYU Langone Health
  • Ioannis Aifantis; New York University School of Medicine
  • Joan Cangiarella; New York University School of Medicine
  • Mark J Mulligan; New York University School of Medicine
  • Ludovic Desvignes; New York University School of Medicine
  • Meike Dittmann; New York University School of Medicine
  • Nathaniel R Landau; New York University School of Medicine
  • Maria E Aguero-Rosenfeld; New York University
  • Shohei Koide; New York University School of Medicine
  • Kenneth A Stapleford Jr.; New York University School of Medicine
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-252353
ABSTRACT
Understanding antibody responses to SARS-CoV-2 is indispensable for the development of containment measures to overcome the current COVID-19 pandemic. Here, we determine the ability of sera from 101 recovered healthcare workers to neutralize both authentic SARS-CoV-2 and SARS-CoV-2 pseudotyped virus and address their antibody titers against SARS-CoV-2 nucleoprotein and spike receptor-binding domain. Interestingly, the majority of individuals have low neutralization capacity and only 6% of the healthcare workers showed high neutralizing titers against both authentic SARS-CoV-2 virus and the pseudotyped virus. We found the antibody response to SARS-CoV-2 infection generates antigen-specific isotypes as well as a diverse combination of antibody isotypes, with high titers of IgG, IgM and IgA against both antigens correlating with neutralization capacity. Importantly, we found that neutralization correlated with antibody titers as quantified by ELISA. This suggests that an ELISA assay can be used to determine seroneutralization potential. Altogether, our work provides a snapshot of the SARS-CoV-2 neutralizing antibody response in recovered healthcare workers and provides evidence that possessing multiple antibody isotypes may play an important role in SARS-CoV-2 neutralization.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...